LEADER 05371nam 2200733Ia 450 001 9911019548303321 005 20200520144314.0 010 $a9786610748594 010 $a9781280748592 010 $a1280748591 010 $a9780470763476 010 $a0470763477 010 $a9781444312850 010 $a1444312855 010 $a9781405171380 010 $a1405171383 035 $a(CKB)1000000000341847 035 $a(EBL)284193 035 $a(SSID)ssj0000097013 035 $a(PQKBManifestationID)11526172 035 $a(PQKBTitleCode)TC0000097013 035 $a(PQKBWorkID)10114576 035 $a(PQKB)11190511 035 $a(MiAaPQ)EBC284193 035 $a(OCoLC)352836293 035 $a(Perlego)2750297 035 $a(EXLCZ)991000000000341847 100 $a20050601d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAcute coronary syndromes $ea handbook for clinical practice /$fedited by Michel E. Bertrand, Spencer B. King III 210 $aOxford $cBlackwell$d2006 215 $a1 online resource (320 p.) 225 1 $aThe ESC education series 300 $a"A publication based on ESC guidelines (www.escardio.org/knowledge/guidelines)." 300 $a"European Society of Cardiology." 311 08$a9781405135016 311 08$a1405135018 320 $aIncludes bibliographical references and index. 327 $aAcute coronary syndromes A handbook for clinical practice; List of contributors; Preface; Section one:Epidemiology; CHAPTER 1Epidemiology ofnon-ST-segment elevationacute coronary syndromes:Euro Heart Survey, GRACE,CRUSADEDavid Hasdai and Alexander Battler; Section two:Pathophysiology; CHAPTER 2 Pathologic findings in acute coronary syndromes Erling Falk; CHAPTER 3 Vascular biology of acute coronary syndromes Lina Badimon; Section three:Clinical aspects of ACS; CHAPTER 4 Clinical aspects of acute coronary syndromes Eugene McFadden 327 $aCHAPTER 5 Circulating biomarkers for risk stratification Christopher HeeschenSection four:Investigation in ACS; CHAPTER 6Coronary angiography,angioscopy, andintravascular ultrasound innon-ST-segment elevationacute coronary syndromesEric Van Belle, Christophe Bauters, Franc?ois Schiele, andMichel E. Bertrand; CHAPTER 7New coronary imaging inacute coronary syndromePim J. de Feyter, Evelyne Regar, and Nico R.A. Mollet; Section five:Special groups of patients 327 $aCHAPTER 8Acute coronary syndromesin special groups of patientsPiero O. Bonetti, Michael J. Zellweger, Christoph Kaiser,and Matthias E. PfistererSection six:Pharmacological treatment; CHAPTER 9Antiischemic treatment(nitrates, ?-blockers, calciumantagonists)David McCarty, Colum G. Owens, and A.A. Jennifer Adgey; CHAPTER 10Antiplatelet therapies:aspirin, thienopyridines,andglycoprotein IIb/IIIareceptor inhibitorsJaydeep Sarma and Keith A.A. Fox; CHAPTER 11Antithrombin drugs: LMWH,unfractionated heparin,direct thrombin inhibitorsRaphaelle Dumaine and Gilles Montalescot 327 $aCHAPTER 12Statin therapy in ACSFranc?ois SchieleSection seven:Myocardial revascularization; CHAPTER 13Percutaneous coronaryinterventions andstenting/CABG innon-ST-segment elevationacute coronary syndromesNicolas Meneveau and Jean-Pierre Bassand; Section eight:Therapeutic strategy; CHAPTER 14Risk stratification andtherapeutic strategyChristian W. Hamm; CHAPTER 15Indication forrevascularization innon-ST-elevation acutecoronary syndromeLars Wallentin; CHAPTER 16Management of patients withnonamenable lesions formyocardial revascularizationVictor Legrand 327 $aCHAPTER 17Non-ST-segment elevationcoronary syndromes:European Society ofCardiology guidelinesMichel E. BertrandCHAPTER 18Non-ST-segment elevationacute coronary syndromes:ACC/AHA guidelinesPierre The?roux; CHAPTER 19From guidelinesto registriesLuigi Tavazzi; Section nine:Secondary prevention; CHAPTER 20Secondary prevention afteracute episode ofpatientspresenting with nonpersistentST-segment elevationMichel E. Bertrand; CHAPTER 21How to detect vulnerableplaqueDirk Boese and Raimund Erbel; CHAPTER 22Local versus systemicprevention treatmentMario Togni and Bernhard Meier; Conclusions; Index 330 $aThe management of non-ST segment elevation acute coronary syndromes (NSTE-ACS) has rapidly evolved over the last few years and many guidelines have been provided and already updated. This book is based on the latest ESC Guidelines and reports the current knowledge in NSTE-ACS, together with the most recent therapeutic options and the different strategies that can be applied according to the clinical status of patients. International experts address the different aspects of NSTE-ACS and bring useful information to clinicians, interventionalists and surgeons involved in the difficul 410 0$aESC education series. 606 $aHeart 606 $aCoronary heart disease$vHandbooks, manuals, etc 615 0$aHeart. 615 0$aCoronary heart disease 676 $a616.123 701 $aBertrand$b M$01342268 701 $aKing$b Spencer B.$f1937-$0101677 712 02$aEuropean Society of Cardiology. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019548303321 996 $aAcute coronary syndromes$93065578 997 $aUNINA LEADER 02896nam 2200637 a 450 001 9910964056103321 005 20251116221143.0 010 $a1-61728-253-7 035 $a(CKB)2560000000070112 035 $a(EBL)3019954 035 $a(SSID)ssj0000470688 035 $a(PQKBManifestationID)12158892 035 $a(PQKBTitleCode)TC0000470688 035 $a(PQKBWorkID)10412442 035 $a(PQKB)11495966 035 $a(MiAaPQ)EBC3019954 035 $a(Au-PeEL)EBL3019954 035 $a(CaPaEBR)ebr10674962 035 $a(OCoLC)923662206 035 $a(BIP)27689937 035 $a(EXLCZ)992560000000070112 100 $a20090920d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aKaryogamic theory of cancer cell formation from the view of the XXI century /$fG. Gogichadze and T. Gogichadze 205 $a1st ed. 210 $aNew York $cNova Biomedical Books$dc2010 215 $a1 online resource (195 p.) 225 1 $aCancer etiology, diagnosis and treatments series 300 $aDescription based upon print version of record. 311 08$a1-60876-386-2 320 $aIncludes bibliographical references and index. 327 $aHistory of the problem -- Hybrid cells receiving methods and mechanism of cells fusion -- Geno- and phenotypic characteristics of hybrid cells -- Utilization of somatic hybridization in biology and medicine -- Etiology and pathogenesis of cancer -- Factors, induced the malignant process -- The theory of "two synkaryons" -- Experimental and clinical confirmations of the "two synkaryons" theory -- Explanation of differented complicated aspects of the experimental and clinical oncology from the standpoint of the "two synkaryons" theory -- Etiology and pathogenesis of AIDS -- Possible common etiology and pathogenesis of cancer and AIDS -- A possible reason for interrelation of some malignant tumors and AIDS -- A paradoxical idea of cancer's resolution. 330 $aIn this book mechanisms of development of cancer cells through hybridisation of somatic cells are discussed which leads to the karyogamy, hybridisation, 'two synkaryon' theory of carcinogenesis. 410 0$aCancer etiology, diagnosis, and treatments. 606 $aCarcinogenesis 606 $aCancer cells 606 $aCell hybridization 606 $aAIDS (Disease)$xEtiology 615 0$aCarcinogenesis. 615 0$aCancer cells. 615 0$aCell hybridization. 615 0$aAIDS (Disease)$xEtiology. 676 $a616.99/4071 700 $aGogichadze$b G. K$01864032 701 $aGogichadze$b T$01864033 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910964056103321 996 $aKaryogamic theory of cancer cell formation from the view of the XXI century$94470736 997 $aUNINA